Network pharmacology and molecular docking-based investigation on traditional Chinese medicine Astragalus membranaceus in oral ulcer treatment
Wan Zhong,Si-Yu Tao,Xiang Guo,Xiao-Fang Cheng,Qing Yuan,Chu-Xing Li,Hong-Yuan Tian,Song Yang,Diwas Sunchuri,Zhu-Ling Guo
DOI: https://doi.org/10.1097/md.0000000000034744
IF: 1.6
2023-08-31
Medicine
Abstract:Oral ulcer (OU) is the most common ulcer disease in human beings. OU is characterized by recurrent oral mucosal ulcer in healthy individuals, which occurs in oral mucosa (lip, tongue, soft palate, small tongue, etc). [ 1–3 ] The prevalence of OU in the general population ranges from 5% to 20%. [ 4–6 ] OU caused by epithelial necrosis at the lesion site extend beyond the basement membrane and expose nerve endings, usually causing discomfort or pain. Oral hygiene, anti-inflammatory drugs, local anesthetic agents, oral decontamination, and mouth wash are some of the current therapies used to relieve pain and lessen disease severity in patients. Despite this, most of them are still supportive, and there is no effective treatment at present. [ 7 ] Growth factors, immune modulators, and radioprotection agents have all been discovered in clinical trials and preclinical investigations as OU medicines. [ 8 ] However, these drugs have limited effects, require intravenous injection or frequent administration, and may accelerate neoplastic growth. [ 5 ] Therefore, there is an urgent need to identify OU drugs that are more cost-effective and have fewer side effects.
medicine, general & internal